It’s common for chemotherapy patients to lose their hair, and the loss is supposed to be temporary. Most patients’ hair grows back within months of completing treatment. However, the hair loss allegedly linked to the chemotherapy drug Taxotere may be permanent and irreversible. If you or a loved one has suffered permanent hair loss (alopecia areata) after undergoing chemotherapy for breast cancer, Taxotere or other products containing docetaxel may be the culprit.
What to do if you’ve suffered permanent hair loss from Taxotere
Women who have battled breast cancer may find that this has significantly impacted their quality of life.
You may be entitled to financial compensation if:
- You are a woman who used Taxotere to treat breast cancer.
- You have lost hair that has not grown back after completing treatment.
A class-action lawsuit has been initiated against the manufacturers of Taxotere, alleging that they knew about the risk of permanent hair loss, but failed to warn patients. The FDA finally updated the warning label for Taxotere in December 2015 to include permanent hair loss. Taxotere's packaging now states that "in some cases (frequency not known) permanent hair loss has been observed." But if you or a loved one was prescribed Taxotere prior to this change, you may be eligible for compensation.
Hupy and Abraham is offering free case reviews to breast cancer patients and others whose hair failed to grow back following chemotherapy with Taxotere. About three-quarter of breast cancer patients have used Taxotere. If you are one of those patients, please download our FREE report, “Important Information About Taxotere,” to find out what steps you should take to make a full recovery and potentially receive financial compensation. You can also contact us online or call us directly at 800.800.5678 to schedule a free consultation.